rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-9-23
|
pubmed:abstractText |
We have demonstrated that valproic acid (VPA), a histone deacetylase inhibitor (HDACI), can improve animal survival after hemorrhagic shock, and protect neurons from hypoxia-induced apoptosis. This study investigated whether VPA treatment works through the c-Jun N-terminal kinase (JNK)/Caspase-3 survival pathways.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1095-8673
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
156
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
290-6
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:19665733-Animals,
pubmed-meshheading:19665733-Apoptosis,
pubmed-meshheading:19665733-Caspase 3,
pubmed-meshheading:19665733-Cell Survival,
pubmed-meshheading:19665733-Disease Models, Animal,
pubmed-meshheading:19665733-Enzyme Inhibitors,
pubmed-meshheading:19665733-Histone Deacetylase Inhibitors,
pubmed-meshheading:19665733-JNK Mitogen-Activated Protein Kinases,
pubmed-meshheading:19665733-Liver,
pubmed-meshheading:19665733-Rats,
pubmed-meshheading:19665733-Shock, Hemorrhagic,
pubmed-meshheading:19665733-Signal Transduction,
pubmed-meshheading:19665733-Valproic Acid
|
pubmed:year |
2009
|
pubmed:articleTitle |
Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock.
|
pubmed:affiliation |
Department of Surgery, Division of Trauma, Emergency Surgery, and Surgical Critical Care, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts 02114, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|